Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutationsSatoshi Oizumi, Toshihiro Nukiwa, Yuka Fujita et al.|ESMO Open|2018Cited by 43
Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissuesMasashi Demura, Yoshiyu Takeda, Fen Wang et al.|Journal of Hypertension|2011Cited by 13
Updated survival outcomes of NEJ005/TCOG0902, a randomized phase II study of concurrent (C) versus sequential alternating (S) gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (<i>EGFR</i>) mutations.Satoshi Oizumi, Shunichi Sugawara, Koichi Minato et al.|Journal of Clinical Oncology|2017Cited by 4